REGENXBIO
RGNX
$16.19
Share price
0.81%
Change (1 day)
-12.01%
Change (1 year)
Categories
REGENXBIO (RGNX) - Net assets
Net assets on the balance sheet as of December 2023 : $0.31 B
According to REGENXBIO's latest financial reports the company has $0.31 B in net assets.
A company’s net assets is the sum of its assets minus the sum of its liabilities.
REGENXBIO - Net assets on balance sheet (from 2014 to 2023)
Net assets by year
| Year | Net assets | Change |
|---|---|---|
| 2023-12-31 | $0.31 B | -39.61% |
| 2022-12-31 | $0.51 B | -32.46% |
| 2021-12-31 | $0.76 B | 102.33% |
| 2020-12-31 | $0.37 B | -16.09% |
| 2019-12-31 | $0.45 B | -11.53% |
| 2018-12-31 | $0.50 B | 178.01% |
| 2017-12-31 | $0.18 B | 13.16% |
| 2016-12-31 | $0.16 B | -25.4% |
| 2015-12-31 | $0.21 B | -3904.98% |
| 2014-12-31 | $-5.7 M | 165.89% |
| 2013-12-31 | $-2.15 M |
Net assets for similar companies or competitors
| Company | Net assets | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | $0.22 B | -28.12% | 🇺🇸 USA |